Characterization of critical domains within the tumor suppressor CASZ1 required for transcriptional regulation and growth suppression

Molecular and Cellular Biology

Volumn 32, Issue 8, 2012, Pages 1518-1528

  Virden, Ryan A ^a   Thiele, Carol J ^a   Liu, Zhihui ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMINO ACID; LUCIFERASE; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 1; ZINC FINGER PROTEIN 2; ZINC FINGER PROTEIN 3; ZINC FINGER PROTEIN 4; ZINC FINGER TRANSCRIPTION FACTOR CASZ1B;

AMINO ACID SEQUENCE; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; GENE DELETION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; WILD TYPE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, SCID; MUTATION; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; ZINC FINGERS;

EID: 84861309957     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06039-11     Document Type: Article

References (32)

1. Bagchi A, Mills AA. 2008. The quest for the 1p36 tumor suppressor. Cancer Res. 68:2551-2556.
2. Brady CA, et al. 2011. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell 145:571-583.
3. Brennan P, Donev R, Hewamana S. 2008. Targeting transcription factors for therapeutic benefit. Mol. Biosyst. 4:909-919.
4. Brodeur GM. 2003. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3:203-216.
5. Brody T, Odenwald WF. 2002. Cellular diversity in the developing nervous system: a temporal view from Drosophila. Development 129:3763-3770.
6. Christine KS, Conlon FL. 2008. Vertebrate CASTOR is required for differentiation of cardiac precursor cells at the ventral midline. Dev. Cell 14:616-623.
7. Cui X, Doe CQ. 1992. ming is expressed in neuroblast sublineages and regulates gene expression in the Drosophila central nervous system. Development 116:943-952.
8. De Laurenzi V, et al. 1998. Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med. 188:1763-1768.
9. Eggert A, et al. 2000. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 19:2043-2051.
10. Grimmer MR, Weiss WA. 2006. Childhood tumors of the nervous system as disorders of normal development. Curr. Opin. Pediatr. 18:634-638.
11. Grosskortenhaus R, Robinson KJ, Doe CQ. 2006. Pdm and Castor specify late-born motor neuron identity in the NB7-1 lineage. Genes Dev. 20:2618-2627.
12. Grotzer MA, Castelletti D, Fiaschetti G, Shalaby T, Arcaro A. 2009. Targeting Myc in pediatric malignancies of the central and peripheral nervous system. Curr. Cancer Drug Targets 9:176-188.
13. Harel L, Costa B, Fainzilber M. 2010. On the death Trk. Dev. Neurobiol. 70:298-303.
14. Hitier R, Chaminade M, Preat T. 2001. The Drosophila castor gene is involved in postembryonic brain development. Mech. Dev. 103:3-11.
15. Isshiki T, Pearson B, Holbrook S, Doe CQ. 2001. Drosophila neuroblasts sequentially express transcription factors which specify the temporal identity of their neuronal progeny. Cell 106:511-521.
16. Kambadur R, et al. 1998. Regulation of POU genes by castor and hunchback establishes layered compartments in the Drosophila CNS. Genes Dev. 12:246-260.
17. Killick R, et al. 2011. p73: a multifunctional protein in neurobiology. Mol. Neurobiol. 43:139-146.
18. Liu Z, Naranjo A, Thiele CJ. 2011. CASZ1b, the short isoform of CASZ1 gene, coexpresses with CASZ1a during neurogenesis and suppresses neuroblastoma cell growth. PLoS One 6:e18557.
19. Liu Z, et al. 2011. CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ. 18:1174-1183.
20. Liu Z, Yang X, Tan F, Cullion K, Thiele CJ. 2006. Molecular cloning and characterization of human Castor, a novel human gene upregulated during cell differentiation. Biochem. Biophys. Res. Commun. 344:834-844.
21. Lovat PE, et al. 2002. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Res. 62:5158-5167.
22. Maris JM. 2010. Recent advances in neuroblastoma. N. Engl. J. Med. 362:2202-2211.
23. Matsushima H, Bogenmann E. 1993. Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo. Mol. Cell. Biol. 13:7447-7456.
24. McConville CM, Forsyth J. 2003. Neuroblastoma-a developmental perspective. Cancer Lett. 197:3-9.
25. Mellerick DM, Kassis JA, Zhang SD, Odenwald WF. 1992. castor encodes a novel zinc finger protein required for the development of a subset of CNS neurons in Drosophila. Neuron 9:789-803.
26. Nakagawara A. 2004. Neural crest development and neuroblastoma: the genetic and biological link. Prog. Brain Res. 146:233-242.
27. Rothschild G, Zhao X, Iavarone A, Lasorella A. 2006. E proteins and Id2 converge on p57Kip2 to regulate cell cycle in neural cells. Mol. Cell. Biol. 26:4351-4361.
28. Schramm A, et al. 2005. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Lett. 228:143-153.
29. Schulte JH, et al. 2009. The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo. Int. J. Cancer 124:2488-2494.
30. Summerhill EM, Wood K, Fishman MC. 1987. Regulation of tyrosine hydroxylase gene expression during differentiation of neuroblastoma cells. Brain Res. 388:99-103.
31. Thiele CJ, Li Z, McKee AE. 2009. On Trk-the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin. Cancer Res. 15:5962-5967.
32. Warner LR, et al. 2009. Functional consequences of genetic variation in primates on tyrosine hydroxylase (TH) expression in vitro. Brain Res. 1288:1-8.